Drug intelligence / Profile preview

VaxiTet

Development stage
Unknown
Lead developer
Incepta Pharmaceuticals
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

VaxiTet is an adsorbed tetanus toxoid vaccine developed and manufactured by Incepta Vaccine Ltd. in Bangladesh. It is a biologic product consisting of purified tetanus toxin produced by the bacterium *Clostridium tetani*, which is detoxified with formaldehyde and adsorbed onto aluminum phosphate. The vaccine is indicated for active immunization against tetanus in infants, children aged 7 years and older, and adults. It is also used for the prevention of neonatal tetanus through the immunization of women of childbearing age. VaxiTet works by inducing the production of specific antitoxin antibodies that neutralize the biological activity of the tetanus toxin. It is supplied as a turbid, whitish-gray suspension for intramuscular injection and contains thiomersal as a preservative.

Brand names
VaxiTet
Other names
tetanus toxoid vaccine

Beyond the preview

Go deeper on VaxiTet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VaxiTet.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call